Trong-Nhat Phan

LCB 03-0110, a Novel Pan-Discoidin Domain Receptor/c-Src Family Tyrosine Kinase Inhibitor, Suppresses Scar Formation by Inhibiting Fibroblast and Macrophage Activation

Xiaoyan Sun, Trong-Nhat Phan, Seung Hee Jung et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 38 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei

Trong-Nhat Phan, Kyunghwa Baek, Nakyung Lee et al. · Molecules · 2020 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria Parasites

Μarianna Stampolaki, Satish R. Malwal, Nadine Álvarez et al. · ACS Infectious Diseases · 2023 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Microbiology +13

Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies

Ahmed H.E. Hassan, Kazem Mahmoud, Trong-Nhat Phan et al. · European Journal of Medicinal Chemistry · 2023 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of <i>Leishmania donovani</i>

Ahmed H.E. Hassan, Trong-Nhat Phan, Seolmin Yoon et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14